Best TWAS P=1.56e-11 · Best GWAS P=5.42e-11 conditioned to 0.428
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | E2F1 | 0.06 | 0.01 | bslmm | 268 | 0.02 | 1.6e-03 | -6.0 | 6.0 | 2.1e-09 | 0.06 | 0.04 | 0.74 | FALSE |
2 | GTEx | Artery Tibial | TP53INP2 | 0.09 | 0.08 | lasso | 1 | 0.07 | 5.6e-06 | 5.8 | 5.8 | 6.1e-09 | 0.06 | 0.01 | 0.98 | TRUE |
3 | GTEx | Artery Tibial | GSS | 0.06 | 0.02 | enet | 25 | 0.04 | 7.7e-04 | 5.8 | 6.2 | 6.6e-10 | 0.35 | 0.20 | 0.39 | FALSE |
4 | GTEx | Brain Hippocampus | E2F1 | 0.39 | 0.25 | lasso | 8 | 0.18 | 4.1e-05 | -6.3 | 5.9 | 4.5e-09 | -0.01 | 0.02 | 0.95 | FALSE |
5 | GTEx | Brain Hypothalamus | E2F1 | 0.26 | 0.02 | lasso | 5 | 0.12 | 9.1e-04 | 2.7 | 5.7 | 1.3e-08 | 0.06 | 0.04 | 0.57 | FALSE |
6 | GTEx | Brain Putamen basal ganglia | E2F1 | 0.18 | 0.22 | lasso | 6 | 0.21 | 1.2e-05 | -6.3 | 6.2 | 6.0e-10 | 0.01 | 0.03 | 0.94 | TRUE |
7 | GTEx | Breast Mammary Tissue (Male) | UQCC1 | 0.06 | 0.04 | lasso | 1 | 0.02 | 1.4e-01 | 5.3 | -5.3 | 1.2e-07 | -0.90 | 0.04 | 0.12 | FALSE |
8 | GTEx | Testis | CBFA2T2 | 0.10 | 0.07 | enet | 11 | 0.07 | 6.1e-04 | -6.0 | 6.1 | 1.1e-09 | -0.02 | 0.06 | 0.88 | FALSE |
9 | NTR | Blood | UQCC | 0.01 | 0.01 | enet | 6 | 0.00 | 1.6e-02 | 5.0 | -5.4 | 6.0e-08 | -0.89 | 0.09 | 0.77 | FALSE |
10 | ROSMAP | Brain Pre-frontal Cortex | UQCC1 | 0.05 | 0.05 | lasso | 5 | 0.06 | 1.7e-08 | 5.2 | -5.4 | 5.8e-08 | -0.84 | 0.22 | 0.78 | FALSE |
11 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | UQCC | 0.03 | 0.04 | blup | 67 | 0.03 | 2.6e-03 | 5.0 | -5.4 | 5.2e-08 | -0.91 | 0.02 | 0.91 | FALSE |
12 | The Cancer Genome Atlas | Breast Invasive Carcinoma | GGT7 | 0.02 | 0.02 | lasso | 3 | 0.02 | 2.2e-04 | 5.8 | -5.5 | 3.5e-08 | -0.09 | 0.01 | 0.90 | FALSE |
13 | The Cancer Genome Atlas | Colon Adenocarcinoma | CBFA2T2 | 0.13 | 0.04 | lasso | 1 | 0.03 | 1.1e-02 | -6.2 | 6.2 | 7.1e-10 | 0.01 | 0.01 | 0.69 | FALSE |
14 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CEP250 | 0.02 | 0.01 | blup | 43 | 0.02 | 8.0e-04 | 4.3 | 5.1 | 3.1e-07 | 0.79 | 0.03 | 0.83 | FALSE |
15 | The Cancer Genome Atlas | Brain Lower Grade Glioma | CBFA2T2 | 0.02 | 0.01 | blup | 31 | 0.01 | 1.8e-02 | -6.1 | 5.3 | 9.6e-08 | 0.02 | 0.01 | 0.70 | FALSE |
16 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | UQCC | 0.07 | 0.08 | blup | 67 | 0.07 | 1.1e-08 | 5.0 | -5.1 | 3.1e-07 | -0.82 | 0.05 | 0.95 | FALSE |
17 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | GDF5 | 0.05 | 0.02 | blup | 76 | 0.04 | 1.4e-03 | 5.0 | 5.2 | 2.4e-07 | 0.89 | 0.03 | 0.91 | FALSE |
18 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | UQCC | 0.22 | 0.21 | lasso | 7 | 0.18 | 1.9e-07 | 4.9 | -5.3 | 1.1e-07 | -0.84 | 0.30 | 0.70 | FALSE |
19 | The Cancer Genome Atlas | Prostate Adenocarcinoma | GDF5 | 0.05 | 0.05 | lasso | 5 | 0.04 | 7.2e-05 | 6.6 | 6.0 | 2.6e-09 | 0.95 | 0.00 | 1.00 | FALSE |
20 | The Cancer Genome Atlas | Soft Tissue Sarcoma | UQCC | 0.07 | 0.06 | blup | 66 | 0.07 | 5.2e-05 | 5.0 | -5.3 | 1.2e-07 | -0.89 | 0.02 | 0.97 | FALSE |
21 | The Cancer Genome Atlas | Stomach Adenocarcinoma | GDF5 | 0.09 | 0.04 | enet | 13 | 0.05 | 2.4e-04 | 6.6 | 6.7 | 1.6e-11 | 0.85 | 0.00 | 0.99 | TRUE |
22 | The Cancer Genome Atlas | Thyroid Carcinoma | CEP250 | 0.05 | 0.03 | blup | 43 | 0.04 | 5.8e-05 | 4.3 | 5.3 | 1.2e-07 | 0.78 | 0.12 | 0.83 | FALSE |
23 | The Cancer Genome Atlas | Thyroid Carcinoma | UQCC | 0.15 | 0.21 | blup | 67 | 0.22 | 1.2e-20 | 5.3 | -5.5 | 4.6e-08 | -0.88 | 0.46 | 0.54 | FALSE |